is farxiga a glp-1 drug APhA 2025: Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes GLP-1 Weight Loss Drug Market

GLP-1 RA use in complicated diabetes: There is no clear evidence regarding the use of GLP-1 RA in acute myocardial infarction, although the use of these agents is encouraged in patients with asymptomatic and stable coronary artery disease (CAD)

& DRI6012 Study Investigatiors

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo controlled, randomised clinical trial (SemaPsychiatry)

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms that Affect Motor Function in Patients with Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial

D., Seeger J

What stands out